Recombinant Listeria monocytogenes as a live vaccine vehicle and a probe for studying cell-mediated immunity.
The ability of Listeria monocytogenes (L. monocytogenes) to enter the cytosol of host cells allows secreted proteins to efficiently enter the endogenous antigen-processing pathway leading to presentation by MHC class I molecules. L. monocytogenes has recently been exploited as a live vaccine vehicle for the induction of immunological memory against heterologous antigens. We have established a genetic system for site-specific integration of antigen expression cassettes into the Listeria genome which allows regulated expression and secretion of heterologous proteins. The ability of recombinant strains to stimulate long-term immunological memory and CD8+ T-cell-mediated protective immunity was investigated using the lymphocytic choriomeningitis virus (LCMV) murine infection model. Vaccination of mice with recombinant Listeria strains expressing LCMV antigens induced LCMV-specific CD8+ T cells which protected mice against LCMV challenge. We have also used a cottontail rabbit papillomavirus model to test the ability of recombinant Listeria strains to stimulate protective antitumor immunity in domestic rabbits. These studies have demonstrated the protective efficacy of recombinant L. monocytogenes vaccines and have established an experimental system for systematic analysis of cytotoxic T-cell induction by an intracellular bacterium.
Jensen
E R
ER
Department of Microbiology and Immunology, University of California at Los Angeles School of Medicine, USA.
Shen
H
H
Wettstein
F O
FO
Ahmed
R
R
Miller
J F
JF
D000818:Animals; D012777:Cottontail rabbit papillomavirus / Q000276:immunology; D008089:Listeria monocytogenes / Q000235:genetics*; D008216:Lymphocytic Choriomeningitis / Q000517:prevention & control; D051379:Mice; D030361:Papillomavirus Infections / Q000517:prevention & control; D011817:Rabbits; D014412:Tumor Virus Infections / Q000517:prevention & control; D014614:Vaccines, Synthetic / Q000276:immunology / Q000627:therapeutic use*; D014765:Viral Vaccines / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*
D014614:Vaccines, Synthetic; D014765:Viral Vaccines